Press Center

The new review of the most notable patents disputes in Life Sciences in EAEU and CIS.

• pdf, 13.31 Mb

On the threshold of its 20th anniversary, Lidings is implementing the next stage in the evolution of its management model.

A change of managing partner at a law firm is rarely just a personnel decision – more often, it is a test of the sustainability of the business model and the maturity of the partnership. Lidings partners Andrey Zelenin and his successor as managing partner, Boris Malakhov, argue that their transition was neither a crisis nor a reboot, but rather a confirmation of the viability of the chosen governance structure – one that maintains trust within the team and carefully adapts to a changing market.

Lidings takes high positions in the new rating of the leading legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper. In 2026 the firm is ranked among the TOP leading legal advisors in Russia. 

April 9^th,2026 annual conference Pharmaceuticals – 2026: Legal Issues will take place in Moscow organized by Pravo.ru. Lidings lawyers take an active part in the event’s program.

As a strategic partner of the conference, we aimed to make the program rich and actual. Together with pharmaceutical industry experts and lawyers, we will discuss how the market has changed in 2025 and what awaits us in 2026.

Active public discussions continue regarding the draft law “On the Foundations of State Regulation of Artificial Intelligence Technology Applications in the Russian Federation”, drafted by the Ministry of Digital Development of the Russian Federation. The document covers the development, implementation and use of artificial intelligence (hereinafter – “AI”), and establishes obligations for service owners, developers and users. Below is an overview of the key changes that will affect businesses.

India has long and firmly established itself as the ‘pharmacy of the world’, as the country produces a fifth of all generics and provides affordable medicines to millions of people across the globe. However, India is now transitioning from copying innovative molecules to creating them. Amid the restructuring of global supply chains and strategic rapprochement with Russia, India is becoming both a battleground for fierce patent wars and a unique laboratory for joint research. How can Russian pharmaceutical companies establish intellectual property protection in a jurisdiction where the balance between the interests of pharmaceutical giants and the affordability of medicines for the population is enshrined in law? Boris Malakhov and Natalya Thotahewage analyse the key features of patenting and the prospects for technological alliances between Moscow and Delhi.

On 24 March 2026, the State Duma adopted Bill No. 1136722-8 at its third reading, proposing to transfer the powers to review decisions of magistrates’ courts on cassation appeal from the cassation courts of general jurisdiction to the courts of the constituent entities of the Russian Federation. The initiative was put forward by the Supreme Court of the Russian Federation.

On 24 March 2025, the State Duma adopted, at the third reading, Draft Law No. 1097621-8 (the “Draft Law”), which prohibits employers from imposing a probationary period on women with children under the age of three.